Skip to main content
. 2023 Mar 20;58:101901. doi: 10.1016/j.eclinm.2023.101901

Fig. 2.

Fig. 2

Adapted disease-free survival (A), adapted overall survival (B), adapted breast cancer-free interval (C), and adapted breast cancer-specific mortality (D) in 1660 patients who were disease-free at 3 years after randomisation.